Omitted Financial Disclosure: In the Original Contribution entitled “Decreased β-Amyloid1-42 and Increased Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer Disease” published in the April 23/30, 2003, issue of JAMA (2003;289:2094-2103), the following financial disclosure should have been published. Dr Sunderland reports having received honoraria from and/or consulting for Quintiles, Pfizer, Abbott, Alza, Novartis, Lundbeck, AstraZeneca, and CNS.
Omitted Financial Disclosure in: Decreased β-Amyloid. JAMA. 2007;298(13):1516. doi:10.1001/jama.298.13.1516-b